US Patent Issued to Bristol-Myers Squibb on Sept. 23 for "Tricyclic heteroaryl compounds useful as IRAK4 inhibitors" (New Jersey Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,230, issued on Sept. 23, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Tricyclic heteroaryl compounds useful as IRAK4 inhibitors" was invented by Saleem Ahmad (Wall, N.J.) and Lidet A. Negash (Plainsboro, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of Formulas (I) or (II) or a salt thereof, wherein X, R1, R2, R3, and n are defined herein. Also disclosed are methods of using such compounds as modulators of IRAK4, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases, or in the treatment of cancer." ...